News

All Blog Investor News

Emyria releases Annual Report

Aug 30, 2022

Emyria releases Annual Report

Emyria’s Ultra – Pure CBD is a Step Closer to Registration

Aug 18, 2022

Emyria’s Ultra – Pure CBD is a Step Closer to Registration

Ethics Approval for EMD-RX5 – Clinical Trials Next

Aug 17, 2022

Ethics Approval for EMD-RX5 – Clinical Trials Next

Forrest’s Tenmile – Highlights Investment in Emyria

Aug 15, 2022

Forrest’s Tenmile – Highlights Investment in Emyria

Step forward in the push for evidence-based CBD treatments

Aug 09, 2022

Step forward in the push for evidence-based CBD treatments

Recent EFSA Decision Highlights Real World Data’s Importance

Jul 12, 2022

Recent EFSA Decision Highlights Real World Data’s Importance

How Can Remote Monitoring Improve Our Healthcare System?

Jul 07, 2022

How Can Remote Monitoring Improve Our Healthcare System?

Promising EMD-RX5 Phase One Clinical Trial results unpacked

Jun 08, 2022

Promising EMD-RX5 Phase One Clinical Trial results unpacked

Investor Webinar | Drug Development Update

Jun 02, 2022

Investor Webinar | Drug Development Update

1
2
…
5
Next